$NASDAQ:VTRS

Investors in Viatris (VTRS) Have Opportunity to Lead Securities Fraud Lawsuit

🌧️Trending News Investors in Viatris Inc ($NASDAQ:VTRS). (VTRS) have an opportunity to lead the securities fraud lawsuit against the company. [...]

By |July 11, 2023|Categories: Drug Manufacturers - Specialty & Generic|Tags: , , |0 Comments
Read More

Viatris Inc Stock Intrinsic Value – Jakubowitz Law Investigates Potential Violations of Federal Securities Laws by Viatris

Trending News 🌧️ Jakubowitz Law is currently conducting an investigation into whether Viatris Inc ($NASDAQ:VTRS). has violated federal securities laws. [...]

By |May 17, 2023|Categories: Drug Manufacturers - Specialty & Generic, Intrinsic Value|Tags: , , |0 Comments
Read More

FDA Rejects Viatris’s Biosimilar Marketing Application for Cancer Therapy Bevacizumab.

Trending News 🌧️ On Friday, Biocon, the Indian partner of Viatris Inc ($NASDAQ:VTRS)., a global healthcare company with a mission [...]

By |February 15, 2023|Categories: Drug Manufacturers - Specialty & Generic|Tags: , , |0 Comments
Read More

Viatris Consumer-Health Assets Attract Potential €3billion Offers from CVC Capital Partners.

Trending News ☀️ Viatris Inc ($NASDAQ:VTRS). is a publicly traded healthcare company that is formed through the merger of Mylan [...]

By |February 12, 2023|Categories: Drug Manufacturers - Specialty & Generic|Tags: , , |0 Comments
Read More

Investing Everyone Can Do.

Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.

Web App

Support Portal

Go to Top